Mechanism of signal transduction that regulates osteoclast differentiation and its abnormalities in bone distructive diseases
Mechanism of signal transduction that regulates osteoclast differentiation and its abnormalities in bone distructive diseases
批准号:
11470227
负责人:
MATSUMOTO Toshio
金额:
$7.87万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2001
中文摘要
1. 克隆RANKL诱导的破骨细胞祖细胞人白血病细胞株HL60的早期基因,在TPA和1,25 -维生素d诱导分化后表达RANK。RANKL处理由此诱导的HL60细胞可进一步上调RANK。同时,我们通过抑制PCR方法,用RANKL刺激破骨细胞祖细胞(包括原代小鼠脾细胞和小鼠破骨细胞前细胞系C7) 1至4小时,鉴定了几个RANKL靶基因。这些基因包括组织蛋白酶和未表征的转录因子。阐明诱导这些靶基因的RANKL信号通路将有助于鉴定调控破骨细胞分化的主控基因。多发性骨髓瘤(MM)细胞诱导破骨细胞的机制我们证实了巨噬细胞炎症蛋白(MIP)-1 α和β是由MM细胞大量产生的。这些趋化因子不仅通过其共同受体CCR5诱导基质细胞表达RANKL,而且还以自分泌/旁分泌的方式激活MM细胞上的vla4,从而增强细胞与在其表面表达VCAM-1的基质细胞的相互作用。我们还发现MIP-1增强MM细胞与破骨细胞的结合。成骨细胞的存在以依赖于直接细胞间相互作用的方式增强了MM细胞的增殖和存活。这些影响似乎涉及基质蛋白,如破骨细胞大量产生的骨桥蛋白,以及白细胞介素-6,一种已知的MM细胞生长因子。综上所述,这些结果表明骨髓环境中复杂的细胞相互作用,其中MIP-1可能发挥核心作用,不仅导致破骨细胞的有效活化,而且还增强MM的增殖和存活,从而导致恶性循环,导致严重的骨破坏。
英文摘要
1. Cloning of RANKL-induced early genes in osteoclast progenitorsHuman leukemia cell line, HL60, expressed RANK upon differentiation induced by TPA and 1, 25-vitamin D. RANKL treatment of thus induced HL60 cells led to further up-regulation of RANK.Meanwhile, we have identified several RANKL target genes with suppression PCR methods by stimulating osteoclast progenitors including primary mouse spleen cells and a mouse preosteoclast cell line, C7, with RANKL for one to four hours. Among such genes are cathepsins and uncharacterized transcription factors. Elucidation of RANKL signaling pathways that induce these target genes would lead to identification of master genes that regulates osteoclast differentiation.2. Mechanism of osteoclast induction by multiple myeloma (MM) cellsWe demonstrated macrophage inflammatory protein (MIP)-1 alpha and beta are abundantly produced by MM cells. These chemokines not only induced RANKL expression by stromal cells via their common receptor CCR5, but also acts in an autocrine/paracrine fashion to activate VLA-4 on MM cells, thereby enhancing cellular interactions with stromal cells which express VCAM-1 on their surface. We also found that MIP-1 enhances binding of MM cells to osteoclasts. Proliferation and survival of MM cells was enhanced by the presence of osteclasts in a manner dependent on direct cell-cell interactions. These effects appeared to involve matrix proteins such as osteopontin abundantly produced by osteoclasts as well as interleukin-6, a known growth factor for MM cells.Taken together, these results suggested that complex cellular interactions in the bone marrow milieu, in which MIP-1 may play a central role, leads to not only efficient activation of osteoclasts but also enhancement of MM proliferation and survival, thereby causing a vicious cycle that leads to profound bone destruction.
期刊论文(106)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Takeuchi Y, et al.: "Interleukin-11 as a stimulatory factor for bone formation prevents bone loss with advancing age in mice"Journal of Biological Chemistry. 277. 49011-49018 (2002)
Takeuchi Y 等人:“Interleukin-11 作为骨形成的刺激因子,可防止小鼠随着年龄增长而骨质流失”《生物化学杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kitagawa H, et al.: "Ligand selective potentiation of rat mineralocorticoid receptor activation function-1 (AF-1) by a CBP-containing HAT complex"Mol Cell Biol. 22. 3698-706 (2002)
Kitakawa H 等人:“含有 CBP 的 HAT 复合物对大鼠盐皮质激素受体激活功能 1 (AF-1) 的配体选择性增强”Mol Cell Biol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takeda S,et al.: "Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: Studies using VDR knockout mice."Endocrinology. 140. 1005-1008 (1999)
Takeda S 等人:“1,25-二羟基维生素 D 刺激破骨细胞形成需要其与成骨细胞中的维生素 D 受体 (VDR) 结合:使用 VDR 敲除小鼠进行的研究。”内分泌学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Saika M, et al.: "17-beta estradiol stimulates expression of osteoprotegerin (OPG) by a mouse stromal cell line, ST-2, via estrogen receptor alpha"Endocrinology. 142・6. 2205-2212 (2001)
Saika M 等人:“17-β 雌二醇通过雌激素受体 α 刺激小鼠基质细胞系 ST-2 表达骨保护素 (OPG)”内分泌学 142·6 (2001)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Abe M, et al.: "Interleukin-1b (IL-1b) enhances and interferon g (IFNg) suppresses activin A actions by reciprocally regulating activin A and follistatin secretion from bone marrow stromal fibroblasts"Clin Exp Immunol. 126. 64-68 (2001)
Abe M 等人:“白细胞介素 1b (IL-1b) 通过相互调节骨髓基质成纤维细胞的激活素 A 和卵泡抑素分泌来增强激活素 A 的作用,而干扰素 g (IFNg) 则抑制激活素 A 的作用”。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 47 条
Role and mechanism of action of IL-11 on the regulation of bone and adipose tissue interaction
-
批准号:16H05327
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.15万
-
财政年份:2016
-
负责人:MATSUMOTO Toshio
-
依托单位:
Elucidation of molecular mechanism of the regulation of skeletal homeostasis, and development of new therapeutic approaches against skeletal disorders
-
批准号:25293215
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.81万
-
财政年份:2013
-
负责人:MATSUMOTO Toshio
-
依托单位:
Relationships among skeletal, adipose and vasclar regulatory system, and elucidation of pathogensis caused by disturbances of these systems
-
批准号:20249050
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$30.7万
-
财政年份:2008
-
负责人:MATSUMOTO Toshio
-
依托单位:
Observational study of the first stars of the Universe
-
批准号:18204018
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$22.46万
-
财政年份:2006
-
负责人:MATSUMOTO Toshio
-
依托单位:
Molecular mechanic sum of the regulation and dies regulation of bone homeostasis and Development of therapeutic approaches
-
批准号:17209035
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$30.37万
-
财政年份:2005
-
负责人:MATSUMOTO Toshio
-
依托单位:
Differentiation-inducing signals in osteoblasts and its application for development of bone anabolic therapy
-
批准号:14370329
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.83万
-
财政年份:2002
-
负责人:MATSUMOTO Toshio
-
依托单位:
Development of immunotherapy targeting neoplastic lymphocyte-specific antigen (2D7) against hematological malignancies
-
批准号:13557082
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.85万
-
财政年份:2001
-
负责人:MATSUMOTO Toshio
-
依托单位:
Development of novel agents using the method of modulating the transcriptional activity of apo (a) gene
-
批准号:10557105
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$8.32万
-
财政年份:1998
-
负责人:MATSUMOTO Toshio
-
依托单位:
Infrared Observation of Galactid Halo
-
批准号:06402002
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$22.14万
-
财政年份:1994
-
负责人:MATSUMOTO Toshio
-
依托单位:
Development of a new therapeutic approach for senile osteoporosis using bone matrix deoorin
-
批准号:06557055
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$5.7万
-
财政年份:1994
-
负责人:MATSUMOTO Toshio
-
依托单位:
Role of matrix proteins in the local regulation of bone metabolism and its abonomalities in osteoporosis
-
批准号:06454336
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.54万
-
财政年份:1994
-
负责人:MATSUMOTO Toshio
-
依托单位:
DEVELOPMENT OF MID-INFRARED DETECTOR FOR ASTRONOMY
-
批准号:04554003
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$12.99万
-
财政年份:1992
-
负责人:MATSUMOTO Toshio
-
依托单位:
Cell Biological Investigation of Disturbances in Bone Cell Functions with their Application to the Treatment of Osteoporosis
-
批准号:03454217
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.03万
-
财政年份:1991
-
负责人:MATSUMOTO Toshio
-
依托单位:
Purification of prostate-derived bone growth factor and its application to the treatment of osteoporosis
-
批准号:02557111
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$7.23万
-
财政年份:1990
-
负责人:MATSUMOTO Toshio
-
依托单位:
Rocket Observation of Cosmic Infrared Radiation
-
批准号:63045015
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$4.16万
-
财政年份:1988
-
负责人:MATSUMOTO Toshio
-
依托单位:
Development of the multi-element infrared detector
-
批准号:63840003
-
项目类别:Grant-in-Aid for Developmental Scientific Research
-
资助金额:$6.27万
-
财政年份:1988
-
负责人:MATSUMOTO Toshio
-
依托单位:
Infrared Observation of the Early Universe
-
批准号:58420003
-
项目类别:Grant-in-Aid for General Scientific Research (A)
-
资助金额:$23.04万
-
财政年份:1983
-
负责人:MATSUMOTO Toshio
-
依托单位:
国内基金
海外基金
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
-
批准号:82370885
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨
-
依托单位:
Pre-osteoclast调控的血管-骨形成偶联在骨性关节炎发病进展中的机制研究
-
批准号:81601942
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:崔壮
-
依托单位:
一个潜在的、防治骨质破坏的药物靶点的新发现
-
批准号:30670997
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:许多荣
-
依托单位: